journal article·2022-10

Promoting Re-epithelialization in an oxidative diabetic wound microenvironment using self-assembly of a ROS-responsive polymer and P311 peptide micelles

Rong Shi, Haisheng Li, Xin Jin, Xue Huang, Zelin Ou, Xuanfen Zhang, Gaoxing Luo, Jun Deng

Acta Biomaterialia· Volume 152
Publisher page

Abstract

Engineering smart nano-therapeutics for re-epithelialisation of chronic wounds facilitates the wound healing process. However, due to excessive oxidative stress damage and persistent inflammation in diabetic wound microenvironment, the migration of stimulating epidermal cells in diabetic wounds represents a significant challenge. Here we synthesised P311-loaded micelles by self-assembly of P311 peptides and diblock copolymer poly (ethylene glycol)-block-poly (propylene sulfide) (PEG-b-PPS, denoted as PEPS) that have unique ability to transform an oxidative wound microenvironment into a proregenerative one while also providing cues for epidermal cell migration. The P311@PEPS showed an accelerated migration of epidermal cells via activation of the Akt signalling pathway, simultaneously suppressing the unfavourable oxidative wound microenvironment by scavenging reactive oxygen species (ROS), ultimately leading to the induction of an environment conducive to cell migration. Furthermore, the micelles were able to bypass the inhibitory effect of ROS on the Akt signalling pathway, thereby promoting epidermal cell migration. Additionally, we observed that diabetic wounds treated with P311@PEPS showed accelerated chronic wound healing, granulation tissue formation, collagen deposition and re-epithelialisation, thereby suggesting the efficacy of P311@PEPS as a promising nanoplatform for the treatment of chronic wounds. STATEMENT OF SIGNIFICANCE: Based on the unique conditions of the diabetic wound microenvironment, a smart drug delivery system with ROS-responsive nanomaterials has been widely investigated to enhance diabetic wound healing. In our previous studies, we observed that P311 promotes epidermal cell migration to induce wound re-epithelialisation. However, the application of P311 suffers from its instability. Herein, we developed a therapeutic platform with P311-loaded micelles (P311@PEPS), which were synthesized by the self-assembly of P311 peptides and diblock copolymer poly (ethylene glycol)-block-poly (propylene sulfide) (PEG-b-PPS, denoted as PEPS). These micelles provide continuous migration signals for epidermal cells by ROS-trigged P311 release. Additionally, P311@PEPS scavenges excess ROS and provides a microenvironment that reduces inflammation, which could protect P311 from enzymatic degradation and improve the bioavailability of P311.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Wound Healing and Treatments · Antimicrobial Peptides and Activities · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (74)

Show source-provided references
1. Human wounds and its burden: an updated compendium of estimates10.1089/wound.2019.0946 ↗
2. An economic evaluation of the impact, cost, and medicare policy implications of chronic nonhealing wounds10.1016/j.jval.2017.07.007 ↗
3. Negative pressure wound therapy for treating foot wounds in people with diabetes mellitus
4. Nanomedicines and gene therapy for the delivery of growth factors to improve perfusion and oxygenation in wound healing10.1016/j.addr.2018.02.001 ↗
5. BBB pathophysiology-independent delivery of siRNA in traumatic brain injury10.1126/sciadv.abd6889 ↗
6. Wound healing: from passive to smart dressings10.1002/adhm.202100477 ↗
7. Immunoregulation in diabetic wound repair with a photoenhanced glycyrrhizic acid hydrogel scaffold10.1002/adma.202200521 ↗
8. Hyperbaric oxygen-generating hydrogels10.1016/j.biomaterials.2018.08.032 ↗
9. Advanced drug delivery systems and artificial skin grafts for skin wound healing10.1016/j.addr.2018.12.014 ↗
10. Stem cell dynamics, migration and plasticity during wound healing10.1038/s41556-018-0237-6 ↗
11. Deregulated immune cell recruitment orchestrated by FOXM1 impairs human diabetic wound healing10.1038/s41467-020-18276-0 ↗
12. High-glucose environment disturbs the physiologic functions of keratinocytes: focusing on diabetic wound healing10.1016/j.jdermsci.2016.07.008 ↗
13. NIR-II photo-amplified sonodynamic therapy using sodium molybdenum bronze nanoplatform against subcutaneous staphylococcus aureus Infection
14. Inflammation, ROS, and mutagenesis10.1016/j.ccell.2017.11.015 ↗
15. Promoting angiogenesis in oxidative diabetic wound microenvironment using a nanozyme-reinforced self-protecting hydrogel10.1021/acscentsci.8b00850 ↗
16. Wound healing: a cellular perspective10.1152/physrev.00067.2017 ↗
17. High glucose environment induces M1 macrophage polarization that impairs keratinocyte migration via TNF-α: an important mechanism to delay the diabetic wound healing10.1016/j.jdermsci.2019.11.004 ↗
18. Electrically stimulated cell migration and its contribution to wound healing10.1186/s41038-018-0123-2 ↗
19. Anisotropic biomimetic silk scaffolds for improved cell migration and healing of skin wounds10.1021/acsami.8b18626 ↗
20. Calcium silicate accelerates cutaneous wound healing with enhanced re-epithelialization through EGF/EGFR/ERK-mediated promotion of epidermal stem cell functions10.1093/burnst/tkab029 ↗
21. GDF-5 induces epidermal stem cell migration via RhoA-MMP9 signalling10.1111/jcmm.15925 ↗
22. Helical peptide and protein design10.1016/S1367-5931(99)00031-9 ↗
23. Designing helical peptide inhibitors of protein-protein interactions10.1016/j.sbi.2016.04.001 ↗
24. P311 in scar wars: myofibroblasts Lost without transforming growth factor β translation10.1165/rcmb.2018-0255ED ↗
25. P311 facilitates the angiogenesis and wound healing function of MSCs by Increasing VEGF production
26. P311 promotes lung fibrosis via stimulation of transforming growth factor-β1, -β2, and -β3 translation10.1165/rcmb.2018-0028OC ↗
27. Chicoric acid prevents PDGF-BB-induced VSMC dedifferentiation, proliferation and migration by suppressing ROS/NFκB/mTOR/P70S6K signaling cascade10.1016/j.redox.2017.11.012 ↗
28. Construction of heparin-based hydrogel incorporated with Cu5.4O ultrasmall nanozymes for wound healing and inflammation inhibition
29. Reactive oxygen species (ROS)-based nanomedicine10.1021/acs.chemrev.8b00626 ↗
30. Ultrasmall copper-based nanoparticles for reactive oxygen species scavenging and alleviation of inflammation related diseases10.1038/s41467-020-16544-7 ↗
31. Sensitive activatable nanoprobes for real-time ratiometric magnetic resonance imaging of reactive oxygen species and ameliorating inflammation in vivo10.1002/adma.202109004 ↗
32. ROS-scavenging hydrogel to promote healing of bacteria infected diabetic wounds10.1016/j.biomaterials.2020.120286 ↗
33. Polymeric micelles: theranostic co-delivery system for poorly water-soluble drugs and contrast agents10.1016/j.biomaterials.2018.03.054 ↗
34. Surface engineering of FLT4-targeted nanocarriers enhances cell-softening glaucoma therapy10.1021/acsami.1c09294 ↗
35. Reactive oxygen species (ROS)-responsive biomaterials mediate tissue microenvironments and tissue regeneration10.1039/C9TB00847K ↗
36. Oxidation-responsive polymeric vesicles10.1038/nmat1081 ↗
37. Near-infrared laser-triggered, self-immolative smart polymersomes for in vivo cancer therapy10.2147/IJN.S224502 ↗
38. Inflammation-targeted celastrol nanodrug attenuates collagen-induced arthritis through NF-kappaB and Notch1 pathways10.1021/acs.nanolett.0c03279 ↗
39. Manipulation of environmental oxygen modifies reactive oxygen and nitrogen species generation during myogenesis10.1016/j.redox.2016.01.011 ↗
40. Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways10.1186/s13046-020-01611-0 ↗
41. Impact of silica nanoparticle design on cellular toxicity and hemolytic activity10.1021/nn2013904 ↗
42. Akap1 deficiency exacerbates diabetic cardiomyopathy in mice by NDUFS1-mediated mitochondrial dysfunction and apoptosis10.1007/s00125-020-05103-w ↗
43. Legumain promotes tubular ferroptosis by facilitating chaperone-mediated autophagy of GPX4 in AKI10.1038/s41419-020-03362-4 ↗
44. Ferrostatin-1 alleviates angiotensin II (Ang II)- induced inflammation and ferroptosis in astrocytes10.1016/j.intimp.2020.107179 ↗
45. The lysosomal membrane protein LAMP2A promotes autophagic flux and prevents SNCA-induced Parkinson disease-like symptoms in the Drosophila brain10.1080/15548627.2018.1491489 ↗
46. In-situ degradation of sulphur mustard and its simulants on the surface of impregnated carbon systems10.1016/j.jhazmat.2005.09.053 ↗
47. Aggregation-induced emission luminogens for activity-based sensing10.1021/acs.accounts.9b00305 ↗
48. Direct observation of aggregation-induced emission mechanism10.1002/anie.202004318 ↗
49. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents10.1038/s41580-020-0230-3 ↗
50. Investigating the role of P311 in the hypertrophic scar10.1371/journal.pone.0009995 ↗
51. P311-induced myofibroblasts exhibit ameboid-like migration through RalA activation10.1016/j.yexcr.2006.07.016 ↗
52. P311 induces a TGF-beta1-independent, nonfibrogenic myofibroblast phenotype10.1172/JCI0215614 ↗
53. Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis10.1136/annrheumdis-2016-210229 ↗
54. P311 induces the transdifferentiation of epidermal stem cells to myofibroblast-like cells by stimulating transforming growth factor β1 expression10.1186/s13287-016-0421-1 ↗
55. Keratinocyte autophagy enables the activation of keratinocytes and fibroblastsand facilitates wound healing10.1080/15548627.2020.1816342 ↗
56. A biological membrane-based novel excisional wound-splinting model in mice (With video)10.4103/2321-3868.143625 ↗
57. Redox signaling in diabetic wound healing regulates extracellular matrix deposition10.1089/ars.2017.7263 ↗
58. Oxidized CaMKII and O-GlcNAcylation cause increased atrial fibrillation in diabetic mice by distinct mechanisms10.1172/JCI95747 ↗
59. A thermoreversible antibacterial zeolite-based nanoparticles loaded hydrogel promotes diabetic wound healing via detrimental factor neutralization and ROS scavenging10.1186/s12951-021-01151-5 ↗
60. ROS-scavenging hydrogel to promote healing of bacteria infected diabetic wounds10.1016/j.biomaterials.2020.120286 ↗
61. Targeted and activatable nanosystem for fluorescent and optoacoustic imaging of immune-mediated inflammatory diseases and therapy via inhibiting NF-κB/NLRP3 pathways
62. Influence of curcumin on performance and post-exercise recovery10.1080/10408398.2020.1754754 ↗
63. The zinc transporter ZIP7 (Slc39a7) controls myocardial reperfusion injury by regulating mitophagy10.1007/s00395-021-00894-4 ↗
64. P311 accelerates skin wound reepithelialization by promoting epidermal stem cell migration through RhoA and Rac1 activation10.1089/scd.2016.0249 ↗
65. Delayed hair follicle morphogenesis and hair follicle dystrophy in a lipoatrophy mouse model of Pparg total deletion10.1016/j.jid.2017.09.024 ↗
66. Involvement of PPAR nuclear receptors in tissue injury and wound repair10.1172/JCI27958 ↗
67. PPARβ/δ: linking metabolism to regeneration10.3390/ijms19072013 ↗
68. PPARD and interferon gamma promote transformation of gastric progenitor cells and tumorigenesis in mice10.1053/j.gastro.2019.03.018 ↗
69. Low-concentration DMSO accelerates skin wound healing by Akt/mTOR-mediated cell proliferation and migration in diabetic mice10.1111/bph.15052 ↗
70. Insulin promotes macrophage phenotype transition through PI3K/Akt and PPAR-γ signaling during diabetic wound healing10.1002/jcp.27185 ↗
71. Insulin promotes macrophage phenotype transition through PI3K/Akt and PPAR-γ signaling during diabetic wound healing10.1002/jcp.27185 ↗
72. Epidermal PPARγ is a key homeostatic regulator of cutaneous inflammation and barrier function in mouse skin10.3390/ijms22168634 ↗
73. Subchronic and chronic toxicity evaluation of inorganic nanoparticles for delivery applications10.1016/j.addr.2019.07.006 ↗
74. Overview of the blood compatibility of nanomedicines: a trend analysis of in vitro and in vivo studies10.1002/wnan.1546 ↗